-
Curaleaf Q3 Results: Strong Margins But $44M Loss, What's Next For Investors?
Wednesday, November 6, 2024 - 6:41pm | 413The company reported a net loss of $44 million, equivalent to $0.07 per share, with adjusted EBITDA at $75.3 million. Curaleaf Holdings, Inc. (OTC:CURLF) posted its third-quarter revenue of $331 million on Wednesday afternoon, marking a modest 1% year-over-year decline. Gross profit reached $160.5...
-
TerrAscend Expands Footprint Despite Q3 Losses, Can A Move To Ohio Turn The Tide?
Wednesday, November 6, 2024 - 6:24pm | 408The company recently secured a $140 million senior loan maturing in 2028, carrying a 12.75% interest rate, with no prepayment penalties. Positive Cash Flow Amid Market Challenges TerrAscend Corp. (OTC:TSNDF) reported its third-quarter revenue of $74.2 million Wednesday afternoon marking a 4.3%...
-
Earnings Season Looms Large: Here's When Leading Marijuana Lender And This Cannabis Company Will Report Results
Tuesday, October 15, 2024 - 12:18pm | 571AFC Gamma AFC Gamma, Inc. (NASDAQ:AFCG) will report earnings for the quarter ended Sept. 30, 2024 on Wednesday, Nov. 13, 2024. The West Palm Beach, Florida-based company will host a conference call to discuss its quarterly financial results at 10:00 am ET the same day. AFC Gamma is one of the...
-
Cannabis Giant Green Thumb To Report Q3 Results, Here's What Investors Should Watch For
Thursday, October 3, 2024 - 7:53pm | 707Cannabis consumer packaged goods company Green Thumb Industries Inc. (CSE:GTII) (OTCQX:GTBIF) and owner of RISE Dispensaries, announced on Thursday that it will release its third quarter 2024 financial results after the market closes on Nov.7, 2024. A conference call and audio webcast will be held...
-
Billion-Dollar Cannabis Giant Tilray To Report Earnings, Here's What Investors Can Expect
Tuesday, October 1, 2024 - 12:22pm | 686Tilray Brands, Inc. (NASDAQ:TLRY) will release its financial results on Oct. 10, 2024 before financial markets open and host a live conference call to discuss the results at 8:30 am ET the same day. In July, Tilray reported fiscal fourth-quarter revenue of $229.882 million, up approximately 25%...
-
Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials
Thursday, September 5, 2024 - 9:22am | 507Irish psychedelic biotech firm GH Research PLC (NASDAQ:GHRS) reported its financial results for the second quarter ended June 30, 2024. Q2 2024 Financial Highlights Cash, cash equivalents, other financial assets and marketable securities were $204.5 million as of June 30, 2024, compared to cash,...
-
cbdMD Reduces Operating Loss, Reports Positive Net Income For Q3 And 15% YoY Drop In Net Sales
Thursday, August 15, 2024 - 2:51pm | 493cbdMD, Inc. (NYSE:YCBD), an operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs announced its financial results on Wednesday for the third quarter of fiscal 2024 ending June 30, 2024. Year-over-year, operational losses improved markedly,...
-
Blüm Cannabis Co. Reports 111% Increase In Q2 Revenue Following 'Transformative' Sale Of Santa Ana Dispensary
Thursday, August 15, 2024 - 12:48pm | 404California cannabis company Blüm Holdings, Inc. (OTCQB:BLMH) announced its second-quarter financial results on Thursday for the three months ended June 30, 2024. Patty Chan, the company's CFO called Blüm's financial results and sale of Blüm Santa Ana "financial milestones" and "the culmination of...
-
Decibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches
Wednesday, August 14, 2024 - 10:33am | 568Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) reported on Wednesday its unaudited interim financial results for the second quarter ending June 30, 2024. “Decibel has shown good discipline in reducing our current liabilities by ~5mm this quarter," said Benjamin Sze, Decibel’s...
-
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
Wednesday, August 14, 2024 - 9:43am | 735IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results on Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million ($10.8 million) in the second quarter of 2023. The...
-
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
Wednesday, August 14, 2024 - 8:50am | 485Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its financial results on Wednesday for the second quarter ended June 30, 2024, revealing an 8% year-over-year and 6% sequential increase to CA$10.3 million ($7.5 million). “We are...
-
Organigram Reports 25% YoY Increase In Q3 Net Revenue, Significant Improvement In Adjusted EBITDA
Tuesday, August 13, 2024 - 8:51am | 707Cannabis producer Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) announced its financial results on Tuesday for the third quarter ended June 30, 2024, revealing net revenue increased 25% year-over-year to CA$41.1 million ($29.9 million). Beena Goldenberg, the company's CEO, praised the revenue...
-
CBG Producer Willow Biosciences Reports Record Q2 Revenue, Enters Major Pharma Deal Slated To Be Key Driver Of Growth
Monday, August 12, 2024 - 3:30pm | 539Willow Biosciences Inc. (TSX: WLLW) (OTCQB:CANSF) reported its financial and operating results on Monday for the three months ended June 30, 2024, reporting significantly higher revenue and reduced costs. “The second quarter was marked by significant pipeline and revenue growth with the...
-
This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now
Friday, August 9, 2024 - 11:37am | 822Vext Vext Science, Inc. (CSE:VEXT) (OTCQX:VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024, before the market opens on Tuesday, Aug. 20, 2024. A conference call and webcast will take place...
-
Canopy Growth Q1 Revenue Drops 13% YoY, Reports Wider Net Loss
Friday, August 9, 2024 - 10:09am | 496Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced its financial results Friday for the first quarter ended June 30, 2024. The Canadian cannabis giant reported a record quarter for Canadian medical marijuana, with new revenue surging 20% year-over-year and representing the 6th consecutive...